RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
OncoSec Medical Stock

OncoSec Medical Equity 2024

OncoSec Medical Equity

6.12 M USD

Ticker

ONCS

ISIN

US68234L3069

WKN

A2PKW3

In 2024, OncoSec Medical's equity was 6.12 M USD, a -83.93% increase from the 38.08 M USD equity in the previous year.

OncoSec Medical Aktienanalyse

What does OncoSec Medical do?

OncoSec Medical Inc is a US-based company specializing in the development of cancer treatment methods through immunotherapy. The company was founded in 2011 and is headquartered in San Diego, California. The history of OncoSec Medical Inc began with the idea of improving tumor treatments through electroporation. Electroporation is a process that uses electric pulses to increase the permeability of cell membranes. This facilitates the exchange of molecules and the uptake of drugs, which is used in the treatment of cancer cells. The business model of OncoSec Medical Inc is based on the development and commercialization of immunotherapies to combat cancer. Electroporation is used to locally infect tumor lesions with reactivated T-cells and other immune cells to generate an immune response. OncoSec Medical Inc has developed a proprietary platform called ImmunoPulse, which combines electroporation and immunotherapy. The company is divided into various divisions, including research and development, clinical trials, manufacturing, and distribution. Research and development focus on identifying potential immunotherapies and testing drug candidates. Clinical trials are designed to confirm the effectiveness and safety of therapies through clinical testing. Manufacturing involves the production of drug candidates and clinical preparations in accordance with Good Manufacturing Practices (GMPs). Distribution includes the sale and marketing of approved therapies to patients and healthcare providers. OncoSec Medical Inc offers a variety of immunotherapies for the treatment of various types of cancer. This includes ImmunoPulse IL-12 therapy, which is used to treat metastatic melanoma. The company is also working on several other therapies, including the Verapamil-Plus-IL-2 protocol for the treatment of breast and prostate cancer. In summary, OncoSec Medical Inc is an emerging biotechnology company specializing in the development and commercialization of immunotherapies to combat cancer. Through its proprietary ImmunoPulse platform and extensive research and development, the company strives to provide effective and safe treatment options for cancer patients, fully harnessing the potential of immunotherapy. OncoSec Medical ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing OncoSec Medical's Equity

OncoSec Medical's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding OncoSec Medical's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating OncoSec Medical's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

OncoSec Medical's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in OncoSec Medical’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about OncoSec Medical stock

What is the equity of OncoSec Medical this year?

OncoSec Medical has equity of 6.12 M USD this year.

What was the equity of OncoSec Medical compared to the previous year?

The equity of OncoSec Medical has increased/decreased by -83.93% decreased compared to the previous year.

What impact does a high equity have on investors of OncoSec Medical?

A high equity is advantageous for investors of OncoSec Medical as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of OncoSec Medical?

A low equity can be a risk for investors of OncoSec Medical, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of OncoSec Medical affect the company?

An increase in equity of OncoSec Medical can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of OncoSec Medical affect the company?

A reduction in equity of OncoSec Medical can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of OncoSec Medical?

Some factors that can affect the equity of OncoSec Medical include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of OncoSec Medical so important for investors?

The equity of OncoSec Medical is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can OncoSec Medical take to change the equity?

To change equity, OncoSec Medical can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does OncoSec Medical pay?

Over the past 12 months, OncoSec Medical paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, OncoSec Medical is expected to pay a dividend of 0 USD.

What is the dividend yield of OncoSec Medical?

The current dividend yield of OncoSec Medical is .

When does OncoSec Medical pay dividends?

OncoSec Medical pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of OncoSec Medical?

OncoSec Medical paid dividends every year for the past 0 years.

What is the dividend of OncoSec Medical?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is OncoSec Medical located?

OncoSec Medical is assigned to the 'Health' sector.

Wann musste ich die Aktien von OncoSec Medical kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of OncoSec Medical from 10/21/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/21/2024.

When did OncoSec Medical pay the last dividend?

The last dividend was paid out on 10/21/2024.

What was the dividend of OncoSec Medical in the year 2023?

In the year 2023, OncoSec Medical distributed 0 USD as dividends.

In which currency does OncoSec Medical pay out the dividend?

The dividends of OncoSec Medical are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The OncoSec Medical stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von OncoSec Medical

Our stock analysis for OncoSec Medical Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of OncoSec Medical Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.